List view / Grid view

Dave Elder (JPAG Member and David P Elder Consultancy)

Filter the results

 

article

ICH Q12: Technical and regulatory considerations for pharmaceutical product lifecycle management

11 November 2019 | By

The International Conference on Harmonisation (ICH) is drafting guidance for product lifecycle management (ICH Q12) – currently stage 2b, which requires application of the concepts of Quality by Design (QbD) to ongoing lifecycle management and change control. Dave Elder dissects the guidance and discusses considerations for industry professionals.

article

Elemental impurities testing and specification limits – ICH Q3D

22 December 2018 | By

The introduction of ICH Q3D (Guideline for Elemental Impurities)1 was an additional safety-based guidance for toxic impurities that complemented the existing ICH Q3C(R5) (Impurities: Guideline for residual solvents)2 and ICH M7(R1) (Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk);3 as well as the…